Skip to main content

Table 4 Results of the multispectral simulation for the three differentiation tasks

From: Evaluating the suitability of hyper- and multispectral imaging to detect foliar symptoms of the grapevine trunk disease Esca in vineyards

   

VNIR

 

SWIR

HSI

Multispectral

 

HSI

Multispectral

186

2

3

4

5

6

7

8

9

10

RE

288

2

3

4

5

6

7

8

9

10

2016

Symptomatic (original)

CA (%)

73

60

66

71

72

74

75

75

76

76

70

73

58

60

63

65

66

67

68

69

70

TPR (%)

71

77

71

70

72

72

79

77

77

78

71

70

66

66

66

65

69

66

73

71

74

FPR (%)

29

37

39

27

26

25

26

26

24

24

30

34

50

40

35

35

34

35

33

30

32

Symptomatic (annotated)

CA (%)

92

68

69

79

84

86

91

90

91

91

82

88

61

85

85

86

86

86

87

87

87

TPR (%)

89

69

72

78

83

86

88

88

88

88

86

86

84

71

71

75

76

77

79

81

81

FPR (%)

0

32

31

19

13

10

6

6

7

6

22

2

48

1

1

3

3

6

4

7

6

Pre-symptomatic

CA (%)

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

TPR (%)

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

FPR (%)

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

2017

Symptomatic (original)

CA (%)

70

57

61

66

70

70

71

72

72

73

68

81

62

66

71

74

78

78

79

81

83

TPR (%)

73

80

68

74

74

72

73

78

76

77

72

82

81

77

75

80

84

82

81

84

86

FPR (%)

32

45

42

39

33

32

32

31

30

30

35

26

44

43

34

31

27

27

23

22

18

Symptomatic (annotated)

CA (%)

90

67

77

73

85

85

86

87

86

89

83

95

65

66

71

77

79

84

87

88

89

TPR (%)

90

74

76

81

87

89

89

89

88

91

84

90

77

77

79

78

78

86

86

89

87

FPR (%)

11

41

22

34

16

17

15

14

15

13

19

6

44

33

31

24

22

16

12

11

11

Pre-symptomatic

CA (%)

62

53

54

56

59

60

61

62

63

65

59

74

57

62

65

66

67

68

70

71

71

TPR (%)

63

38

54

48

61

65

66

60

56

64

56

78

68

71

71

70

77

73

81

77

77

FPR (%)

35

36

39

36

44

36

32

33

34

31

37

32

52

45

40

41

39

36

36

35

36

2018

Symptomatic (original)

CA (%)

77

63

63

73

75

75

76

76

77

77

68

80

60

60

68

70

72

75

75

77

79

TPR (%)

72

74

66

73

76

74

74

77

77

80

67

74

56

60

64

67

68

74

78

78

82

FPR (%)

22

41

33

35

25

22

23

25

24

23

31

20

41

37

27

30

28

23

25

21

20

Symptomatic (annotated)

CA (%)

94

71

80

81

82

83

89

90

91

91

84

92

67

73

76

79

85

87

87

88

89

TPR (%)

93

71

81

82

82

85

89

89

91

90

83

100

68

65

73

72

83

84

86

87

88

FPR (%)

5

25

21

20

17

16

11

10

10

10

16

5

28

17

17

16

12

10

12

10

9

Pre-symptomatic

CA (%)

79

62

66

68

70

71

74

74

75

76

69

86

60

63

65

75

77

78

80

81

82

TPR (%)

83

77

73

78

82

82

78

80

81

80

72

87

54

71

63

78

80

80

82

84

79

FPR (%)

28

41

35

39

24

35

31

31

29

29

34

21

42

40

42

24

22

22

19

17

19

  1. CA  classification accuracy, TPR   true-positive rate, FPR   false-positive rate, HSI  Hyperspectral Imaging, RE  simulation RedEdge™ wavelengths, 186/288 = wavelength bands of the hyperspectral sensors, 2–10 = number of selected spectral bands